The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway (original) (raw)

References

• Agapova LS, Ivanov AV, Sablina AA, Kopnin PB, Sokova OI, Chumakov PM and Kopnin BP. . 1999 Oncogene 18: 3135–3142.
• Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ and Cowley S. . 1994 EMBO J. 13: 1610–1619.
• Bitangcol JC, Chau AS, Stadnick E, Lohka MJ, Dicken B and Shibuya EK. . 1998 Mol. Biol. Cell 9: 451–467.
• Boulikas T. . 1995 Crit. Rev. Eukaryot. Gene Expr. 5: 1–77.
• Chen RH, Sarnecki C and Blenis J. . 1992 Mol. Cell. Biol. 12: 915–927.
• Daum JR and Gorbsky GJ. . 1998 J. Biol. Chem. 273: 30622–30629.
• de Vries JE, Kornips FH, Marx P, Bosman FT, Geraedts JP and ten Kate J. . 1993 Cancer Genet. Cytogenet. 67: 35–43.
• Denko NC, Giaccia AJ, Stringer JR and Stambrook PJ. . 1994 Proc. Natl. Acad. Sci. USA 91: 5124–5128.
• Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM and Sturgill TW. . 1992 Science 257: 1404–1407.
• Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW and Harris PE. . 1999 Clin. Endocrinol. (Oxf.) 50: 529–535.
• Finney RE and Bishop JM. . 1993 Science 260: 1524–1527.
• Francis-Lang H, Zannini M, De Felice M, Berlingieri MT, Fusco A and Di Lauro R. . 1992 Mol. Cell. Biol. 12: 5793–5800.
• Fukasawa K, Rulong S, Resau J, Pinto da Silva and Woude GF. . 1995 Oncogene 10: 1–8.
• Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M and Vecchio G. . 1987 Mol. Cell. Biol. 7: 3365–3370.
• Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H. . 1995 Science 268: 1766–1769.
• Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A and Vecchio G. . 1990 Cell 60: 557–563.
• Ichikawa T, Kyprianou N and Isaacs JT. . 1990 Cancer Res. 50: 6349–6357.
• Ichikawa T, Schalken JA, Ichikawa Y, Steinberg GD and Isaacs JT. . 1991 Prostate 18: 163–172.
• Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S and Ledent C. . 1996 Endocrinology 137: 375–378.
• Kosako H, Gotoh Y and Nishida E. . 1994 EMBO J. 13: 2131–2138.
• Kupperman E, Wen W and Meinkoth JL. . 1993 Mol. Cell Biol. 13: 4477–4484.
• Loeb LA. . 1997 Science 277: 1449–1450.
• Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR and McCormick F. . 1990 Science 249: 655–659.
• Meloche S. . 1995 J. Cell Physiol. 163: 577–588.
• Miller BM and Nusse M. . 1993 Mutagenesis 8: 35–41.
• Miller MJ, Prigent S, Kupperman E, Rioux L, Park SH, Feramisco JR, White MA, Rutkowski JL and Meinkoth JL. . 1997 J. Biol. Chem. 272: 5600–5605.
• Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA and Meinkoth JL. . 1998 Mol. Cell Biol. 18: 3718–3726.
• Minshull J, Sun H, Tonks NK and Murray AW. . 1994 Cell 79: 475–486.
• Muller WU, Nusse M, Miller BM, Slavotinek A, Viaggi S and Streffer C. . 1996 Mutat. Res. 366: 163–169.
• Namba H, Rubin SA and Fagin JA. . 1990 Mol. Endocrinol. 4: 1474–1479.
• Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H and Fagin JA. . 1997 Cancer Res. 57: 1690–1694.
• Nusse M, Beisker W, Kramer J, Miller BM, Schreiber GA, Viaggi S, Weller EM and Wessels JM. . 1994 Methods Cell Biol. 42: (Pt B) 149–158.
• O'Sullivan CO, Barton CM, Staddon SL, Brown CL and Lemoine NR. . 1991 Mol. Carcinogen. 4: 345–349.
• Oller AR, Rastogi P, Morgenthaler S and Thilly WG. . 1989 Mutat. Res. 216: 149–161.
• Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. . 1993 Nature 365: 649–651.
• Porcellini A, Fenzi G and Avvedimento EV. . 1997 J. Mol. Med. 75: 567–575.
• Powell Jr DJ, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A and Rothstein JL. . 1998 Cancer Res. 58: 5523–5528.
• Roger PP, Reuse S, Maenhaut C and Dumont JE. . 1995 Vitam. Horm. 51: 59–191.
• Saavedra HI, Fukasawa K, Conn CW and Stambrook PJ. . 1999 J. Biol. Chem. 274: 38083–38090.
• Shapiro PS, Vaisberg E, Hunt AJ, Tolwinski NS, Whalen AM, McIntosh JR and Ahn NG. . 1998 J. Cell Biol. 142: 1533–1545.
• Shapiro PS, Whalen AM, Tolwinski NS, Wilsbacher J, Froelich-Ammon SJ, Garcia M, Osheroff N and Ahn NG. . 1999 Mol. Cell Biol. 19: 3551–3560.
• Shirokawa J, Elisei R, Knauf JA, Wang J, Hara T and Fagin JA. . 1999 81st Annual Meeting of The Endocrine Society, June 12–15.
• Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C and Monier R. . 1991 Oncogene 6: 677–679.
• Suarez HG, du Villard JA, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R. . 1988 Oncogene 2: 403–406.
• Takenaka K, Moriguchi T and Nishida E. . 1998 Science 280: 599–602.
• Thacker J. . 1985 Mutat. Res. 150: 431–442.
• Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells Jr SA and Goodfellow PJ. . 1997 Genes Chromosomes Cancer 19: 43–51.
• Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A. . 1995 Oncogene 11: 1207–1210.
• Wani MA, Xu X and Stambrook PJ. . 1994 Cancer Res. 54: 2504–2508.
• Ward LS, Brenta G, Medvedovic M and Fagin JA. . 1998 J. Clin. Endocrinol. Metab. 83: 525–530.
• Woessner RD, Chung TD, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH and Johnson RK. . 1990 Cancer Res. 50: 2901–2908.
• Yang T, Namba H, Hara T, Takmura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K and Yamashita S. . 1997 Oncogene 14: 1511–1519.
• York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW and Stork PJ. . 1998 Nature 392: 622–626.
• Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, Gorbsky GJ and Weber MJ. . 1998 J. Cell Biol. 142: 1547–1558.

Download references